Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Zensar Technologies Merger & Restructuring

Zensar Technologies has received in-principle board approval to merge its US-based step-down subsidiaries, Bridgeview Life Sciences LLC and M3BI LLC, into Zensar Technologies Inc.

Source

NSE filing, NSE: ZENSARTECH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Zensar Technologies Ltd: key numbers

Share price
₹565.75
Market cap
₹12,875 Cr
Revenue (annual)
₹5,687 Cr
Net profit (annual)
₹774.6 Cr
P/E (TTM)
16.4×Sector 23.8×
Promoter holding
48.98%-0.01% QoQ
FII holding
10.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zensar Technologies Ltd

All →

Other merger & restructuring announcements

All →